About Aurenar
Aurenar develops non-invasive neuromodulation devices to modulate inflammation and support intensive care patients.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Seed
Global Headquarters
Saint Louis, United States
Tracked Since
Sep 29, 2026
Web & Domain Identity
Official Website
aurenar.com
Domain Registered Date
Jan 30, 2023
Social & Network Presence
X / Twitter Profile
Not linked
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Raised $5,700,000 · Seed
fundraisingfox.com
- Milestone
Website domain registered
aurenar.com
Investors & Backers
Investor firms and individual backers were not publicly disclosed in available round filings for Aurenar.
Funding History
Seed
· Jul 28, 2026
$5,700,000
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026